Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  ganetespib
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
Paclitaxel and Ganetespib in Treating Patients with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GYN-064, NCI-2013-01416, NCT01962948
I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 097517, NCI-2015-00014, NCT01042379
Hsp90 inhibitor STA-9090 With or Without Dutasteride in Treating Patients With Hormone-Resistant Prostate Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 10-333, NCI-2011-00909, NCT01368003
Ganetespib in Treating Patients With Previously Treated Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-039, NCI-2011-03090, NCT01551693
Fulvestrant with or without Ganetespib in Treating Patients with Hormone-Receptor Positive, Advanced or Metastatic Breast Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 11-477, NCI-2012-00995, F8151631, NCT01560416
Ganetespib, Paclitaxel, and Trastuzumab in Treating Patients with Advanced or Metastatic HER2+ Breast Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-168, NCI-2014-00177, NCT02060253
Start Over